Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Pediatr Crit Care Med. 2023 May 31;24(9):715–726. doi: 10.1097/PCC.0000000000003281

Figure 1.

Figure 1.

Number of patients treated with non-invasive ventilation (NIV) at PARDS diagnosis and success rate, depending on the presence of a high non-respiratory PELOD-2 score, immunosuppression, severe hypoxemia (PaO2/FiO2 <100), a combination of these factors.